United States
Germany
Japan
United Kingdom
China
Transient overexpression lysate of diacylglycerol kinase, alpha 80kDa (DGKA), transcript variant 4
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Products
Transient overexpression lysate of diacylglycerol kinase, alpha 80kDa (DGKA), transcript variant 2
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
LY404427 is the same product as LY430857.
DGKA MS Standard C13 and N15-labeled recombinant protein (NP_963848)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
DGKA MS Standard C13 and N15-labeled recombinant protein (NP_001336)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
DGKA MS Standard C13 and N15-labeled recombinant protein (NP_958853)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
DGKA MS Standard C13 and N15-labeled recombinant protein (NP_958852)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
DGKA HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
DGKA HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
DGKA HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
DGKA (untagged)-Human diacylglycerol kinase, alpha 80kDa (DGKA), transcript variant 1
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL6 |
Dgka (untagged) - Mouse diacylglycerol kinase, alpha (Dgka), (10ug)
| Type | Mouse Untagged Clone |
| Tag | Tag Free |
| Vector | PCMV6-Kan/Neo |
DGKA - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Dgka - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
DGKA (C-term) mouse monoclonal antibody, clone M5a, Purified
| Applications | IP, WB |
| Reactivities | Human |
DGKA mouse monoclonal antibody, clone OTI6B3 (formerly 6B3)
| Applications | IF, WB |
| Reactivities | Human |
